AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVEX THERAPEUTICS LTD

0.120

0.000

Volume:- -

Turnover:- -

Market Cap:9.02M

PE:-19.05

High:0.120

Open:0.120

Low:0.120

Close:0.120

52wk High:0.180

52wk Low:0.059

Shares:75.15M

Float Shares:46.42M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.006

ROE:-8.72%

ROA:-7.65%

PB:1.72

PE(LYR):-19.05

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVEX THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2019

Employees:

- -

Office Location:

38 Rowland Street,Level 2,Subiaco,Western Australia,Australia

Website:

http://www.invextherapeutics.com

Zip Code:

6008

Phone:

Fax:

- -

Introduction:

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IXC.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"IXC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","market":"AU","secType":"STK","nameCN":"INVEX THERAPEUTICS LTD","latestPrice":0.12,"timestamp":1770688602071,"preClose":0.12,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"INVEX THERAPEUTICS LTD","floatShares":46419706,"shares":75153848,"eps":-0.0063,"marketStatus":"Trading","change":0,"latestTime":"02-10 15:42:00 AEDT","open":0.12,"high":0.12,"low":0.12,"amount":0,"amplitude":0,"askPrice":0.13,"askSize":30553,"bidPrice":0.12,"bidSize":63495,"shortable":3,"etf":0,"ttmEps":-0.0063,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.12,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IXC.AU\",,,,,undefined,":{"symbol":"IXC.AU","floatShares":46419706,"roa":"-7.65%","roe":"-8.72%","lyrEps":-0.0063,"shares":75153848,"dividePrice":0,"high":0.12,"amplitude":0,"preClose":0.12,"low":0.12,"week52Low":0.059,"pbRate":"1.72","psRate":"39.37","week52High":0.18,"institutionHeld":0,"latestPrice":0.12,"committee":0.350268,"eps":-0.0063,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0063,"open":0.12,"prevYearClose":0.12,"prevWeekClose":0.12,"prevMonthClose":0.13,"prevQuarterClose":0.12,"fiveDayClose":0.125,"twentyDayClose":0.13,"sixtyDayClose":0.125,"dividendGrowthYears":0,"fiveYearAvgDividendRate":3.105},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXC.AU\",params:#limit:5,,,undefined,":[{"date":"2023-12-08","symbol":"IXC.AU","amount":0.1863,"announcedDate":"2023-11-30","type":"dividend","market":"AU","newRecordDate":"2023-12-11","defaultRemindTime":1701990000000,"name":"Invex Therapeutics","recordDate":"2023-12-18","payableDate":"2023-12-11","currency":"AUD","dateTimestamp":1701954000000,"payDate":"2023-12-18"},{"date":"2023-04-20","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1681948800000,"name":null,"time":"","dateTimestamp":1681912800000,"actualEps":null},{"date":"2023-01-25","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1674601200000,"name":null,"time":"","dateTimestamp":1674565200000,"actualEps":null},{"date":"2022-10-27","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666825200000,"name":null,"time":"","dateTimestamp":1666789200000,"actualEps":null},{"date":"2022-07-06","symbol":"IXC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1657065600000,"name":null,"time":"","dateTimestamp":1657029600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2023-12-18","value":0.1863,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":614309842,"yearFounded":2019,"address":"38 Rowland Street,Level 2,Subiaco,Western Australia,Australia","zipCode":"6008","officePhone":"61 8 6382 0137"},"stockCompanyDetail":{"websiteUrl":"http://www.invextherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.04},{"period":"1month","weight":0.0909},{"period":"3month","weight":0},{"period":"6month","weight":0.6},{"period":"1year","weight":0.6438},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0007},{"period":"3month","weight":0.0188},{"period":"6month","weight":0.0736},{"period":"1year","weight":0.2073},{"period":"ytd","weight":0.0101}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury. The company was incorporated in 2019 and is based in Subiaco, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.047687},{"month":2,"riseRate":0.5,"avgChangeRate":-0.047862},{"month":3,"riseRate":0.666667,"avgChangeRate":0.147696},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.015989},{"month":5,"riseRate":0,"avgChangeRate":-0.16993},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.029146},{"month":7,"riseRate":0.714286,"avgChangeRate":0.071585},{"month":8,"riseRate":0.714286,"avgChangeRate":0.084367},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.074966},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041219},{"month":11,"riseRate":0.571429,"avgChangeRate":0.067784},{"month":12,"riseRate":0.857143,"avgChangeRate":0.057464}],"exchange":"ASX","name":"INVEX THERAPEUTICS LTD","nameEN":"INVEX THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IXC.AU\",market:\"AU\",,,undefined,":null}}